Literature DB >> 26256588

2-Arylquinazolin-4(3H)-ones: Inhibitory Activities Against Xanthine Oxidase.

Humaira Zafar, Syed M Saad, Shahnaz Perveen, Rizwana Malik, Ajmal Khan, Khalid M Khan1, Muhammad I Choudhary2.   

Abstract

2-Arylquinazolin-4(3H)-ones (1-25) were synthesized, and evaluated for their xanthine oxidase inhibitory activity. Significant to moderate activities were exhibited by the compounds 1-3, 7, 9, 13-15, 19-21, and 23 with IC50 between 2.80 - 28.13 µM as compared to the standard allopurinol (IC50 (IC50 = 2.01 ± 0.01 µM). Compounds 4-6, 8, 11-12, 16-18, 22, and 24 demonstrated a weak activity with IC50 values 44.60 - 112.60 µM. Nonetheless, compounds 10 and 25 did not show any activity. Amongst all derivatives, compound 2, containing a C-4´ dimethylamino group, was the most potent inhibitor of the enzyme with an IC50 value comparable to the standard. Kinetics studies on the most active compounds (2, 7, 9, 14, 15, 19, and 20) were conducted in order to determine their modes of inhibition and dissociation constants Ki. Some of the compounds of 2-arylquinazolin-4(3H)-one series were thus identified as potential leads for further studies towards the treatment of hyperuricemia and gout.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26256588     DOI: 10.2174/1573406410666150807111336

Source DB:  PubMed          Journal:  Med Chem        ISSN: 1573-4064            Impact factor:   2.745


  2 in total

1.  Dihydroquinazolin-4(1H)-one derivatives as novel and potential leads for diabetic management.

Authors:  Oluwatoyin Babatunde; Shehryar Hameed; Uzma Salar; Sridevi Chigurupati; Abdul Wadood; Ashfaq Ur Rehman; Vijayan Venugopal; Khalid Mohammed Khan; Muhammad Taha; Shahnaz Perveen
Journal:  Mol Divers       Date:  2021-03-01       Impact factor: 2.943

2.  Newly Designed Quinazolinone Derivatives as Novel Tyrosinase Inhibitor: Synthesis, Inhibitory Activity, and Mechanism.

Authors:  Yaru Huang; Jiefang Yang; Yunyang Chi; Chun Gong; Haikuan Yang; Fanxin Zeng; Fang Gao; Xiaoju Hua; Zongde Wang
Journal:  Molecules       Date:  2022-08-29       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.